184 related articles for article (PubMed ID: 23797801)
21. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
Gowda R; Sharma A; Robertson GP
Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
[TBL] [Abstract][Full Text] [Related]
22. Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
Hartman ML; Talar B; Sztiller-Sikorska M; Nejc D; Czyz M
Oncotarget; 2016 Feb; 7(8):9026-40. PubMed ID: 26824319
[TBL] [Abstract][Full Text] [Related]
23. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M
J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733
[TBL] [Abstract][Full Text] [Related]
24. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.
Cruz-Munoz W; Man S; Kerbel RS
Clin Cancer Res; 2009 Aug; 15(15):4867-74. PubMed ID: 19622578
[TBL] [Abstract][Full Text] [Related]
25. Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.
Liu JW; Cai MX; Xin Y; Wu QS; Ma J; Yang P; Xie HY; Huang DS
J Exp Clin Cancer Res; 2010 Aug; 29(1):108. PubMed ID: 20698986
[TBL] [Abstract][Full Text] [Related]
26. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
27. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
Kim SL; Kim SH; Park YR; Liu YC; Kim EM; Jeong HJ; Kim YN; Seo SY; Kim IH; Lee SO; Lee ST; Kim SW
Mol Cancer Res; 2017 Feb; 15(2):141-151. PubMed ID: 28108625
[TBL] [Abstract][Full Text] [Related]
28. Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.
Tao Y; Zhang ML; Ma PC; Sun JF; Zhou WQ; Cao YP; Li LJ
Asian Pac J Cancer Prev; 2012; 13(4):1611-5. PubMed ID: 22799376
[TBL] [Abstract][Full Text] [Related]
29. Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway.
Wu J; Guan M; Wong PF; Yu H; Dong J; Xu J
Food Chem Toxicol; 2012 Sep; 50(9):3019-24. PubMed ID: 22743248
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells.
Ling B; Michel D; Sakharkar MK; Yang J
Drug Des Devel Ther; 2016; 10():3563-3572. PubMed ID: 27843296
[TBL] [Abstract][Full Text] [Related]
31. Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-κB-Cox2 Signaling.
Wang D; Liu P
Med Sci Monit; 2018 Jan; 24():486-502. PubMed ID: 29368698
[TBL] [Abstract][Full Text] [Related]
32. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
Kishida Y; Yoshikawa H; Myoui A
Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
[TBL] [Abstract][Full Text] [Related]
33. B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
Mohammadi A; Najafi S; Amini M; Baradaran B; Firouzamandi M
Melanoma Res; 2023 Jun; 33(3):173-183. PubMed ID: 37053079
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
36. Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
Li C; Guo S; Shi T
Cell Biochem Funct; 2013 Apr; 31(3):263-8. PubMed ID: 23086737
[TBL] [Abstract][Full Text] [Related]
37. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
[TBL] [Abstract][Full Text] [Related]
38. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y
Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
